Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
DNA Repair (Amst). 2011 Apr 3;10(4):398-407. doi: 10.1016/j.dnarep.2011.01.005. Epub 2011 Feb 5.
DNA repair genes are important for maintaining genomic stability and limiting carcinogenesis. We analyzed all single nucleotide polymorphisms (SNPs) of 125 DNA repair genes covered by the Illumina HumanHap300 (v1.1) BeadChips in a previously conducted genome-wide association study (GWAS) of 1154 lung cancer cases and 1137 controls and replicated the top-hits of XRCC4 SNPs in an independent set of 597 cases and 611 controls in Texas populations. We found that six of 20 XRCC4 SNPs were associated with a decreased risk of lung cancer with a P-value of 0.01 or lower in the discovery dataset, of which the most significant SNP was rs10040363 (P for allelic test=4.89 x 10⁻⁴). Moreover, the data in this region allowed us to impute a potentially functional SNP rs2075685 (imputed P for allelic test=1.3 x 10⁻³). A luciferase reporter assay demonstrated that the rs2075685G>T change in the XRCC4 promoter increased expression of the gene. In the replication study of rs10040363, rs1478486, rs9293329, and rs2075685, however, only rs10040363 achieved a borderline association with a decreased risk of lung cancer in a dominant model (adjusted OR=0.80, 95% CI=0.62-1.03 and P=0.079). In the final combined analysis of both the Texas GWAS discovery and replication datasets, the strength of the association was increased for rs10040363 (adjusted OR=0.77, 95% CI=0.66-0.89, P(dominant)=5 x 10⁻⁴ and P for trend=5 x 10⁻⁴) and rs1478486 (adjusted OR=0.82, 95% CI=0.71-0.94, P(dominant)=6 x 10⁻³ and P for trend=3.5 x 10⁻³). Finally, we conducted a meta-analysis of these XRCC4 SNPs with available data from published GWA studies of lung cancer with a total of 12,312 cases and 47,921 controls, in which none of these XRCC4 SNPs was associated with lung cancer risk. It appeared that rs2075685, although associated with increased expression of a reporter gene and lung cancer risk in the Texas populations, did not have an effect on lung cancer risk in other populations. This study underscores the importance of replication using published data in larger populations.
DNA 修复基因对于维持基因组稳定性和限制致癌作用很重要。我们分析了之前进行的一项 1154 例肺癌病例和 1137 例对照的全基因组关联研究(GWAS)中,Illumina HumanHap300(v1.1)BeadChips 覆盖的 125 个 DNA 修复基因的所有单核苷酸多态性(SNP),并在德克萨斯州人群的一个独立的 597 例病例和 611 例对照的研究中复制了 XRCC4SNP 的主要发现。我们发现,在发现数据集的 20 个 XRCC4SNP 中,有 6 个 SNP 与肺癌风险降低相关,其 P 值低于 0.01,其中最显著的 SNP 是 rs10040363(等位基因检验的 P 值为 4.89 x 10⁻⁴)。此外,该区域的数据允许我们推断出一个潜在的功能性 SNP rs2075685(推测等位基因检验的 P 值为 1.3 x 10⁻³)。荧光素酶报告基因检测表明,XRCC4 启动子中的 rs2075685G>T 变化增加了基因的表达。然而,在 rs10040363、rs1478486、rs9293329 和 rs2075685 的复制研究中,只有 rs10040363 在显性模型中与肺癌风险降低呈临界关联(调整后的 OR=0.80,95%CI=0.62-1.03,P=0.079)。在德克萨斯州 GWAS 发现和复制数据集的最终综合分析中,rs10040363 的关联强度增加(调整后的 OR=0.77,95%CI=0.66-0.89,P(显性)=5 x 10⁻⁴,P 趋势=5 x 10⁻⁴)和 rs1478486(调整后的 OR=0.82,95%CI=0.71-0.94,P(显性)=6 x 10⁻³,P 趋势=3.5 x 10⁻³)。最后,我们对这些 XRCC4SNP 进行了荟萃分析,纳入了已发表的肺癌 GWAS 研究的可用数据,包括 12312 例病例和 47921 例对照,其中没有一个 XRCC4SNP 与肺癌风险相关。虽然 rs2075685 与报告基因的表达增加和德克萨斯州人群的肺癌风险相关,但它似乎对其他人群的肺癌风险没有影响。这项研究强调了在更大的人群中使用已发表的数据进行复制的重要性。